RB1 and Parkinson disease: It is of great interest that the RB protein has also been reported to inhibit atherosclerotic abnormalities, myocardial ischemia, inflammation, neural disorders, such as Alzheimer’s or Parkinson’s diseases, amyotrophic lateral sclerosis, and stroke [46–59] in addition to the suppression of carcinogenesis.